A comparison between once-daily and twice-daily administration of metoprolol in the management of hypertension.
The efficacy of metoprolol as an antihypertensive agent was assessed in 20 previously untreated Asian patients with mild to moderate hypertension. After a 4-week run-in period when placebo therapy was given, the patients were given oral metoprolol at a starting dosage of 100 mg twice daily. The dosage of metoprolol was increased at fortnightly intervals until either satisfactory blood pressure control, defined as a diastolic blood pressure of less than 90 mmHg or a greater than 10% fall in pre-treatment diastolic blood pressure, was achieved or a total of 400 mg metoprolol was reached. All 20 patients had satisfactory control of their blood pressures on a twice-daily regimen and the average dosage of metoprolol required was 200 mg daily. For the second part of the study, the medication was changed to a once-daily regimen at the same total dosage of metoprolol. Final efficacy of once-daily therapy was assessed after 8 weeks of treatment. All blood pressure and pulse rate reductions were significant (P < 0.001) from the placebo phase. However, twice-daily and once-daily readings were not significantly different from each other. No side-effects were reported during the study.